Stocks surged in November as the Trump rally took hold, even as retail investors lowered their overall exposure to U.S. stocks, breaking a three month streak. The behavior-based TD Ameritrade Investor Movement Index (IMX), which aggregates Main Street investor positions, fell 5% to 5.53 in November as retail investors decreased their exposure to the U.S. equity markets. Airline stocks such as Southwest Airlines (LUV) , Delta Airlines (DAL) and United Continental Holdings (UAL) were net sold as their prices rose in November. Net selling also continued in the financial sector for a second month. Citigroup (C) and Bank of America (BAC) were net sold even as their prices rose sharply in November. Despite being net sellers of equities in November, TD Ameritrade clients continued net buying in some of the names that have been popular in recent months including dividend payers Verizon Communications (VZ) and AT&T (T) . Each saw their stock prices rebound after declines earlier in the month. Facebook (FB) and Amazon.com (AMZN) have also been popular buys. Both companies share prices declined in November after setting year-to-date highs in October. Net buying also occurred in both Under Armour (UA) and Tesla Motors (TSLA) following their earnings announcements in late October.
More from Video
Amid the Selling, Here's the Big Question Now
How quickly do we find support, is what we'll want to know now, as the correction is occurring while economic optimism builds.
One Tweet Pulls the Rug Out From Under the Indexes
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
A Technical Look at the New Dow Jones Industrial Average
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
Conagra Brands Looks Tastier After Its Upgrade to Buy
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Biogen Bulls Get a Lift From Quant Upgrade and Strengthening Charts
Breaking down an approach to the long side of this biotech stock.